Skip to main content

Research Repository

Advanced Search

Age and the Residual Risk of Cardiovascular Disease following Low Density Lipoprotein-Cholesterol Exposure

König, Carola S.; Mann, Amar; McFarlane, Rob; Marriott, John; Price, Malcolm; Ramachandran, Sudarshan

Authors

Carola S. König

Amar Mann

Rob McFarlane

John Marriott

Malcolm Price

Sudarshan Ramachandran



Abstract

We believe that there is sufficient evidence from basic science, longitudinal cohort studies and randomised controlled trials which validates the low-density lipoprotein cholesterol (LDL-C) or lipid hypothesis. It is important that we can communicate details of the cardiovascular disease (CVD) risk reduction that the average patient could expect depending on the scale of LDL-C decrease following lipid lowering therapy. It is also essential that residual risk (ResR) of CVD be highlighted. To achieve this aim by using existing trial evidence, we developed mathematical models initially for relative risk reduction (RRR) and absolute risk (AR) reduction and then showed that despite optimising LDL-C levels, a considerable degree of ResR remains that is dependent on AR. Age is significantly associated with AR (odds ratio: 1.02, 95% confidence intervals: 1.01–1.04) as was previously demonstrated by analysing the Whickham study cohort using a logistic regression model (age remaining significant even when all the other significant risk factors such as sex, smoking, systolic blood pressure, diabetes and family history were included in the regression model). A discussion of a paper by Ference et al. provided detailed evidence of the relationship between age and AR, based on lifetime LDL-C exposure. Finally, we discussed non-traditional CVD risk factors that may contribute to ResR based on randomised controlled trials investigating drugs improving inflammation, thrombosis, metabolic and endothelial status.

Citation

König, C. S., Mann, A., McFarlane, R., Marriott, J., Price, M., & Ramachandran, S. (in press). Age and the Residual Risk of Cardiovascular Disease following Low Density Lipoprotein-Cholesterol Exposure. Biomedicines, 11(12), 3208. https://doi.org/10.3390/biomedicines11123208

Journal Article Type Article
Acceptance Date Nov 29, 2023
Online Publication Date Dec 2, 2023
Deposit Date Dec 18, 2023
Journal Biomedicines
Publisher MDPI
Peer Reviewed Peer Reviewed
Volume 11
Issue 12
Pages 3208
DOI https://doi.org/10.3390/biomedicines11123208
Keywords General Biochemistry, Genetics and Molecular Biology, Medicine (miscellaneous)


Downloadable Citations